4.3600
-0.1400
(-3.11%)
At close: April 17 at 4:02:01 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
136,388
159,781
238,169
211,498
Total Liabilities Net Minority Interest
79,995
140,920
177,736
120,330
Total Equity Gross Minority Interest
56,393
18,861
60,433
91,168
Total Capitalization
78,714
18,861
82,656
93,646
Common Stock Equity
56,393
18,861
60,433
91,168
Capital Lease Obligations
7,724
8,856
2,737
6,635
Net Tangible Assets
55,771
18,461
59,702
89,120
Working Capital
80,009
86,372
139,441
125,774
Invested Capital
78,714
41,273
82,656
93,646
Tangible Book Value
55,771
18,461
59,702
89,120
Total Debt
30,045
31,268
24,960
9,113
Share Issued
7,480.5210
4,191.0510
3,725.8160
2,057.0850
Ordinary Shares Number
7,480.5210
4,164.0370
3,698.8010
2,030.0700
Treasury Shares Number
--
27.0140
27.0150
27.0150
12/31/2021 - 4/1/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APTA.ST Aptahem AB (publ)
1.6150
+0.94%
ACTI.ST Active Biotech AB (publ)
0.0980
+10.61%
FLUI.ST Fluicell AB (publ)
11.64
-2.18%
ONCO.ST Oncopeptides AB (publ)
1.9820
+0.51%
CMRX Chimerix, Inc.
8.54
-0.12%
GPCR Structure Therapeutics Inc.
21.76
+17.43%
DBVT DBV Technologies S.A.
7.98
+0.88%
TCRT Alaunos Therapeutics, Inc.
2.4800
-7.12%
DRMA Dermata Therapeutics, Inc.
0.7290
+1.25%
ADTX Aditxt, Inc.
2.5000
+13.64%